PURPOSE: Lynch syndrome accounts for 2-4% of all colorectal cancer, and is mainly caused by germline mutations in the DNA mismatch repair genes. Our aim was to characterize the genetic mutation responsible for Lynch syndrome in an extensive Colombian family and to study its prevalence in Antioquia. METHODS: A Lynch syndrome family fulfilling Amsterdam criteria II was studied by immunohistochemistry and by multiplex ligation-dependent probe amplification (MLPA). Results were confirmed by additional independent MLPA, Southern blotting, and sequencing. RESULTS: Index case tumor immunohistochemistry results were MLH1-, MSH2+, MSH6+, and PMS2-. MLPA analysis detected a duplication of exons 12 and 13 of MLH1. This mutation was confirmed and characterized precisely to span 4219 base pairs. Duplication screening in this family led to the identification of six additional carriers and 13 noncarriers. We also screened 123 early-onset independent colorectal cancer cases from the same area and identified an additional unrelated carrier. CONCLUSION: A novel duplication of exons 12 and 13 of the MLH1 gene was detected in two independent Lynch syndrome families from Colombia. A putative founder effect and prescreening Lynch syndrome Antioquia families for this specific mutation before thorough mismatch repair mutational screening could be suggested.
PURPOSE: Lynch syndrome accounts for 2-4% of all colorectal cancer, and is mainly caused by germline mutations in the DNA mismatch repair genes. Our aim was to characterize the genetic mutation responsible for Lynch syndrome in an extensive Colombian family and to study its prevalence in Antioquia. METHODS: A Lynch syndrome family fulfilling Amsterdam criteria II was studied by immunohistochemistry and by multiplex ligation-dependent probe amplification (MLPA). Results were confirmed by additional independent MLPA, Southern blotting, and sequencing. RESULTS: Index case tumor immunohistochemistry results were MLH1-, MSH2+, MSH6+, and PMS2-. MLPA analysis detected a duplication of exons 12 and 13 of MLH1. This mutation was confirmed and characterized precisely to span 4219 base pairs. Duplication screening in this family led to the identification of six additional carriers and 13 noncarriers. We also screened 123 early-onset independent colorectal cancer cases from the same area and identified an additional unrelated carrier. CONCLUSION: A novel duplication of exons 12 and 13 of the MLH1 gene was detected in two independent Lynch syndrome families from Colombia. A putative founder effect and prescreening Lynch syndrome Antioquia families for this specific mutation before thorough mismatch repair mutational screening could be suggested.
Authors: Carlos A Vaccaro; Carlos Sarroca; Benedito Rossi; Francisco Lopez-Kostner; Mev Dominguez; Natalia Causada Calo; Raul Cutait; Adriana Della Valle; Lina Nuñez; Florencia Neffa; Karin Alvarez; Maria Laura Gonzalez; Pablo Kalfayan; Henry T Lynch; James Church Journal: Fam Cancer Date: 2016-07 Impact factor: 2.375
Authors: Erika Maria Monteiro Santos; Mev Dominguez Valentin; Felipe Carneiro; Ligia Petrolini de Oliveira; Fabio de Oliveira Ferreira; Samuel Aguiar Junior; Wilson Toshihiko Nakagawa; Israel Gomy; Victor Evangelista de Faria Ferraz; Wilson Araujo da Silva Junior; Dirce Maria Carraro; Benedito Mauro Rossi Journal: BMC Cancer Date: 2012-02-09 Impact factor: 4.430
Authors: Amy L Masson; Bente A Talseth-Palmer; Tiffany-Jane Evans; Desma M Grice; Garry N Hannan; Rodney J Scott Journal: Hered Cancer Clin Pract Date: 2014-05-24 Impact factor: 2.857
Authors: Mabel Bohorquez; Ruta Sahasrabudhe; Angel Criollo; María Carolina Sanabria-Salas; Alejandro Vélez; Jorge Mario Castro; Juan Ricardo Marquez; Gilbert Mateus; Fernando Bolaños; Cesar Panqueva; Jose Ignacio Restrepo; Juan Dario Puerta; Raul Murillo; María Mercedes Bravo; Gustavo Hernández; Angela Rios; Rodrigo Prieto; Ian Tomlinson; Magdalena Echeverry; Luis G Carvajal-Carmona Journal: Medicine (Baltimore) Date: 2016-10 Impact factor: 1.889
Authors: Benedito Mauro Rossi; Edenir Inêz Palmero; Francisco López-Kostner; Carlos Sarroca; Carlos Alberto Vaccaro; Florencia Spirandelli; Patricia Ashton-Prolla; Yenni Rodriguez; Henrique de Campos Reis Galvão; Rui Manuel Reis; André Escremim de Paula; Luis Gustavo Capochin Romagnolo; Karin Alvarez; Adriana Della Valle; Florencia Neffa; Pablo German Kalfayan; Enrique Spirandelli; Sergio Chialina; Melva Gutiérrez Angulo; Maria Del Carmen Castro-Mujica; Julio Sanchez de Monte; Richard Quispe; Sabrina Daniela da Silva; Norma Teresa Rossi; Claudia Barletta-Carrillo; Susana Revollo; Ximena Taborga; L Lena Morillas; Hélène Tubeuf; Erika Maria Monteiro-Santos; Tamara Alejandra Piñero; Constantino Dominguez-Barrera; Patrik Wernhoff; Alexandra Martins; Eivind Hovig; Pål Møller; Mev Dominguez-Valentin Journal: BMC Cancer Date: 2017-09-05 Impact factor: 4.430